Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT

Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCT

Background: Around one-third of pregnant women suffer from moderate to severe nausea and vomiting, causing physical and emotional distress and reducing their quality of life. There is no cure for nausea and vomiting in pregnancy. Management focuses on relieving symptoms and preventing morbidity, and...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Stephen Robson, Catherine McParlin, Helen Mossop, Mabel Lie, Cristina Fernandez-Garcia, Denise Howel, Ruth Graham, Laura Ternent, Alison Steel, Nicola Goudie, Afnan Nadeem, Julia Phillipson, Manjeet Shehmar, Nigel Simpson, Derek Tuffnell, Ian Campbell, Rew Williams, Margaret E O’Hara, Elaine McColl, Catherine Nelson-Piercy
Format: article
Langue:EN
Publié: NIHR Journals Library 2021
Sujets:
emesis in pregnancy
ondansetron
metoclopramide
Medical technology
R855-855.5
Accès en ligne:https://doaj.org/article/2c1261229c1949d0abcabb7b2b13602d
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/2c1261229c1949d0abcabb7b2b13602d

Documents similaires